Esperion Therapeutics
ESPR
#6751
Rank
โ‚ฌ0.45 B
Marketcap
2,29ย โ‚ฌ
Share price
-3.57%
Change (1 day)
157.53%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -2,68ย โ‚ฌ

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -2,66ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,34ย โ‚ฌ an increase over its 2021 EPS that were of -9,00ย โ‚ฌ.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,68ย โ‚ฌ-19.83%
2022-3,34ย โ‚ฌ-62.87%
2021-9,00ย โ‚ฌ80.38%
2020-4,99ย โ‚ฌ50.14%
2019-3,32ย โ‚ฌ-53.18%
2018-7,10ย โ‚ฌ7.41%
2017-6,61ย โ‚ฌ110.81%
2016-3,14ย โ‚ฌ47.35%
2015-2,13ย โ‚ฌ0.89%
2014-2,11ย โ‚ฌ28.84%
2013-1,64ย โ‚ฌ-89.3%
2012-15,31ย โ‚ฌ
2002-6,45ย โ‚ฌ8.89%
2001-5,92ย โ‚ฌ-83.77%
2000-36,49ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-9,64ย โ‚ฌ 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
0,73ย โ‚ฌ-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
1,75ย โ‚ฌ-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
35,19ย โ‚ฌ-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,60ย โ‚ฌ-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,64ย โ‚ฌ-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA